These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 21184913)
1. Positron emission tomography for benign and malignant disease. Visioni A; Kim J Surg Clin North Am; 2011 Feb; 91(1):249-66. PubMed ID: 21184913 [TBL] [Abstract][Full Text] [Related]
2. PET/CT in oncology: for which tumours is it the reference standard? Collins CD Cancer Imaging; 2007 Oct; 7 Spec No A(Special issue A):S77-87. PubMed ID: 17921085 [TBL] [Abstract][Full Text] [Related]
3. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients. Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344 [TBL] [Abstract][Full Text] [Related]
4. PET in oncology: will it replace the other modalities? Hoh CK; Schiepers C; Seltzer MA; Gambhir SS; Silverman DH; Czernin J; Maddahi J; Phelps ME Semin Nucl Med; 1997 Apr; 27(2):94-106. PubMed ID: 9144854 [TBL] [Abstract][Full Text] [Related]
5. [Cost-effective PET investigations in oncology]. Kálvin B; Fekésházy A; Lengyel Z; Szakáll S; Agoston P; Lengyel E; Székely J; Galuska L; Trón L; Esik O Magy Onkol; 2002; 46(3):203-23. PubMed ID: 12368917 [TBL] [Abstract][Full Text] [Related]
6. Clinical role of positron emission tomography in oncology. Bomanji JB; Costa DC; Ell PJ Lancet Oncol; 2001 Mar; 2(3):157-64. PubMed ID: 11902566 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of contrast-enhanced computed tomography and positron emission tomography with 18-FDG in identifying malignant solitary pulmonary nodules. Dabrowska M; Krenke R; Korczynski P; Maskey-Warzechowska M; Zukowska M; Kunikowska J; Orłowski T; Chazan R Medicine (Baltimore); 2015 Apr; 94(15):e666. PubMed ID: 25881842 [TBL] [Abstract][Full Text] [Related]
9. Characterization of pulmonary lesions with low F-18 FDG uptake using double phase F-18 FDG PET/CT: comparison of visual and quantitative analyses. Kim IJ; Kim SJ; Kim YS; Lee TH; Jeong YJ Neoplasma; 2009; 56(1):33-9. PubMed ID: 19152243 [TBL] [Abstract][Full Text] [Related]
10. 18-fluorine fluorodeoxyglucose positron emission tomography with computerized tomography versus computerized tomography alone for the management of solitary lung nodules with diameters inferior to 1.5 cm. Divisi D; Di Tommaso S; Di Leonardo G; Brianzoni E; De Vico A; Crisci R Thorac Cardiovasc Surg; 2010 Oct; 58(7):422-6. PubMed ID: 20922626 [TBL] [Abstract][Full Text] [Related]
11. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules. Bryant AS; Cerfolio RJ Ann Thorac Surg; 2006 Sep; 82(3):1016-20. PubMed ID: 16928527 [TBL] [Abstract][Full Text] [Related]
12. Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT. Christensen JA; Nathan MA; Mullan BP; Hartman TE; Swensen SJ; Lowe VJ AJR Am J Roentgenol; 2006 Nov; 187(5):1361-7. PubMed ID: 17056930 [TBL] [Abstract][Full Text] [Related]
13. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial. Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593 [TBL] [Abstract][Full Text] [Related]
14. [Cost-effective PET scans in oncology]. Kálvin B; Fekésházy A; Lengyel Z; Szakáll S; Agoston P; Lengyel E; Székely J; Várady E; Galuska L; Trón L; Esik O Orv Hetil; 2002 May; 143(21 Suppl 3):1255-61. PubMed ID: 12077909 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of occult metastatic disease in patients undergoing 18F-FDG PET for primary diagnosis or staging of lung carcinoma and solitary pulmonary nodules. Lee ST; Berlangieri SU; Poon AM; Mitchell P; Pathmaraj K; Tabone K; Byrne AJ; O'Keefe GJ; Knight SR; Clarke CP; Scott AM Intern Med J; 2007 Nov; 37(11):753-9. PubMed ID: 17517082 [TBL] [Abstract][Full Text] [Related]
16. Whole-body Gajjala SR; Hulikal N; Kadiyala S; Kottu R; Kalawat T Indian J Med Res; 2018 Mar; 147(3):256-262. PubMed ID: 29923514 [TBL] [Abstract][Full Text] [Related]
17. Using neighborhood gray tone difference matrix texture features on dual time point PET/CT images to differentiate malignant from benign FDG-avid solitary pulmonary nodules. Chen S; Harmon S; Perk T; Li X; Chen M; Li Y; Jeraj R Cancer Imaging; 2019 Aug; 19(1):56. PubMed ID: 31420006 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management. Dewan NA; Gupta NC; Redepenning LS; Phalen JJ; Frick MP Chest; 1993 Oct; 104(4):997-1002. PubMed ID: 8404239 [TBL] [Abstract][Full Text] [Related]
19. [A proposal for the rational use of the PET in oncology]. Borrego Dorado I; Vázquez Albertino R Rev Esp Med Nucl; 2002 May; 21(3):163-73. PubMed ID: 12206749 [TBL] [Abstract][Full Text] [Related]